How Effective Is Infratil Company's Sales and Marketing Engine?

CDC Data Centres focuses on winning global technology giants and government agencies that need secure, scalable colocation and managed services. Contracts target multi-megawatt deployments with long-term leases and high utilisation to maximize revenue per rack.

One NZ pursues premium mobile subscribers and enterprise accounts, prioritising 5G, fixed wireless and satellite-to-mobile connectivity for low-churn, high-ARPU segments. Enterprise deals bundle connectivity, cloud interconnect and managed services to lift lifetime value.

RHCNZ Medical Imaging targets hospitals, specialist clinics and aging-population patients with high-frequency imaging needs; emphasis is on diagnostic accuracy, quick turnaround and referral relationships to secure repeat revenue and higher-margin procedures.

Infratil sells long-term Power Purchase Agreements (PPAs) to large industrial customers aiming to meet decarbonisation mandates; targets are multi-year contracts that stabilize cash flows and justify capital for new wind and solar capacity.

Infratil positions CDC as a secure, scalable data partner, One NZ as a premium connectivity and enterprise solutions provider, RHCNZ as a clinically-focused imaging network, and renewable assets as reliable, bankable supply for corporate decarbonisation. Pricing and service SLAs match premium segments to defend margins.

These segments drive recurring, high-quality revenue and support asset-backed valuation: CDC lease-backed revenue scales with rack density; One NZ's high-ARPU customers lift EBITDA margins; RHCNZ benefits from ageing-population demand trends; PPAs lock long-term cash flows that reduce volatility for investors. See a related timeline in this History Analysis of Infratil Company.

Sales focus is on institutional procurement and large corporate customers, closing multi-year deals such as 10 – 15 year Master Services Agreements (MSAs) in data centers with enterprise buyers.

Revenue is structured with CPI escalators in MSAs and tariff-like pricing in regulated assets, preserving margins as operating costs rise and delivering predictable cash flow.

Essential services (airports, mobile, healthcare, data centers) convert demand into paid behavior because spending is non-discretionary and switching is costly and operationally disruptive.

In healthcare, higher-margin modality shifts (PET-CT, MRI) and a 9 percent organic growth run-rate into 2026 drive mix improvement; telecom ARPU and low churn sustain recurring revenue.

Strong secular demand for AI-ready capacity underpins future growth; CDC Canberra and Sydney expansions are expected to drive incremental revenue as racks commission through 2025 – 2026. Recent capacity builds align with global hyperscaler trends and support a projected 15 percent rise in proportionate EBITDAF for 2025/2026.

Infratil marketing strategy effectiveness benefits from direct, relationship-led sales into enterprise and cloud customers plus marketplace visibility for wholesale leases; the go-to-market approach leverages existing asset credibility, targeted deal teams, and partner referrals to keep customer acquisition costs manageable.

Interest-rate volatility could raise financing costs and slow hyperscaler capex; slower-than-expected lease-up at CDC campuses or competitive pricing pressure would compress near-term margins despite contractual escalators that mitigate pass-through risk.

The commercial engine appears strong and adaptable: with over NZ$1.3 billion of divestment liquidity and defensive contracted escalators, Infratil sales performance analysis supports outperforming infrastructure peers, assuming smooth execution of CDC campus ramp-up and disciplined reinvestment into digital and healthcare segments; see Business Model Analysis of Infratil Company for deeper context.